| Literature DB >> 26516617 |
Jun Iwatani1, Takuya Ishida2, Tomohiro Donishi3, Satoshi Ukai1, Kazuhiro Shinosaki1, Masaki Terada4, Yoshiki Kaneoke3.
Abstract
INTRODUCTION: One leading hypothesis suggests that schizophrenia (SZ) is a neurodevelopmental disorder caused by genetic defects in association with environmental risk factors that affect synapse and myelin formation. Recent magnetic resonance imaging (MRI) studies of SZ brain showed both gray matter (GM) reduction and white matter (WM) fractional anisotropy reduction. In this study, we used T1-weighted (T1w)/T2-weighted (T2w) MRI ratio images, which increase myelin-related signal contrast and reduce receiver-coil bias.Entities:
Keywords: T1‐weighted/T2‐weighted ratio; magnetic resonance imaging; myelin; nucleus accumbens; schizophrenia; ventral putamen
Mesh:
Year: 2015 PMID: 26516617 PMCID: PMC4614056 DOI: 10.1002/brb3.399
Source DB: PubMed Journal: Brain Behav Impact factor: 2.708
Demographic and clinical characteristics
| SZ | HC | Group difference | |
|---|---|---|---|
| Age, years | 41.4 ± 9.8 | 37.6 ± 9.8 | 0.135 ( |
| Gender (M/F) | 16/13 | 20/13 | 0.665 ( |
| Handedness (R/L) | 27/2 | 33/0 | 0.126 ( |
| Duration of illness, years | 17.1 ± 11.3 | – | – |
| JART‐J scores | 96.7 ± 11.0 | 108 ± 8.3 | 0.0003 (ANOVA) |
| PANSS_T | 64.4 ± 21.7 | – | – |
| PANSS_P | 14.4 ± 5.60 | – | – |
| PANSS_N | 17.4 ± 6.00 | – | – |
| PANSS_G | 32.7 ± 12.0 | – | – |
| GAF | 58.2 ± 14.4 | – | – |
| CPZ dose equivalence, mg | 629 ± 472 | – | – |
| SGAs | 23a | – | – |
| FGAs | 8b | – | – |
| Mood stabilizers | 5c | – | – |
| Antidepressants | 6d | – | – |
| Benzodiazepines | 19e | – | – |
a,b,c,d,eNumber of subjects taking SGAs, FGAs, mood stabilizers, antidepressants, and benzodiazepines, respectively.
JART‐J, Japanese Adult Reading Test; PANSS, Positive and Negative Syndrome Scale; T, total score; P, positive; N, negative; G, general; GAF, Global Assessment of Functioning Scale; CPZ, chlorpromazine; SGAs, second generation antipsychotics; FGAs, first generation antipsychotics.
Figure 1Mean T1‐weighted (T1w)/T2‐weighted (T2w) ratio image for healthy controls (HCs). Bottom: Color maps overlayed on the standard brain represent the signal strength distribution with 0–100th percentile scale. Relatively high signal intensity was distributed around the temporal lobe, cerebellar cortex in both hemispheres. A large part of the sensorimotor areas is missing due to the segmentation procedure (see text in Results). Top: the same color maps are shown with different scale (0–150 percentile) to show relative difference in the occipito‐temporal regions. It is now clearly seen that the primary auditory area (Brodmann area 41), the primary visual area (Brodmann area 17), and V5/MT (Brodmann area 37/19) have high signal intensity compared to the adjacent areas.
Figure 2Mean gray matter (GM) signal intensity for each subject. Both the T1w and T1w/T2w ratio image signal intensity values in GM were inversely related with age. The values were lower in the schizophrenia (SZ) group compared with the healthy control (HC) group, particularly for the T1w/T2w ratio image. Each group's linear regression line is shown with the same color. For the detailed statistical analysis results (Table 2).
The result of ANCOVA with age, gender, handedness, and JART as nuisance covariates
| Gray matter | White matter | |||||||
|---|---|---|---|---|---|---|---|---|
| T1w/T2w | T1w | T1w/T2w | T1w | |||||
|
|
|
|
|
|
|
|
| |
| ANCOVA | 10.883 | 0.002 | 3.621 | 0.062 | 8.183 | 0.006 | 2.107 | 0.152 |
| Covariates | ||||||||
| Age | 57.627 | <0.0001 | 73.581 | <0.0001 | 4.397 | 0.041 | 0.124 | 0.726 |
| Gender | 6.421 | 0.014 | 13.077 | 0.001 | 6.021 | 0.017 | 10.172 | 0.002 |
| Handedness | 1.003 | 0.321 | 8.977 | 0.004 | 1.361 | 0.248 | 0.324 | 0.572 |
| JART‐J | 0.116 | 0.735 | 0.398 | 0.531 | 0.718 | 0.4 | 1.705 | 0.197 |
JART‐J, Japanese Adult Reading Test.
Figure 3Mean white matter (WM) signal intensity for each subject. The T1w/T2w image signal intensity values in WM were inversely related with age in both the schizophrenia (SZ) and healthy control (HC) groups; values were lower in the SZ group than those observed in the HC group, similar the trend observed in the gray matter (GM) values (see Fig. 2). Each group's linear regression line is shown with the same color. We observed a similar tendency in the T1w image values; however, the tendency was less pronounced than that observed in the T1w/T2w image. For the detailed statistical analysis results (Table 2).
Partial correlations between signal intensity and clinical parameters
| T1w/T2w | T1w | |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Gray matter | ||||||
| Duration of illness, years | −0.144 | 0.502 | 0.502 | −0.0302 | 0.889 | 0.889 |
| PANSS_P | −0.344 | 0.150 | 0.100 | −0.0676 | 0.889 | 0.754 |
| PANSS_N | −0.473 | 0.0586 |
| −0.171 | 0.889 | 0.423 |
| PANSS_G | −0.407 | 0.0967 |
| −0.127 | 0.889 | 0.555 |
| GAF | 0.511 | 0.0586 |
| 0.147 | 0.889 | 0.494 |
| CPZ dose equivalence | −0.293 | 0.198 | 0.165 | 0.0432 | 0.889 | 0.841 |
| White matter | ||||||
| Duration of illness, years | −0.147 | 0.493 | 0.493 | −0.0713 | 0.971 | 0.740 |
| PANSS_P | − |
|
| 0.00775 | 0.971 | 0.971 |
| PANSS_N | −0.385 | 0.127 | 0.0634 | 0.0468 | 0.971 | 0.828 |
| PANSS_G | −0.338 | 0.128 | 0.106 | 0.0405 | 0.971 | 0.851 |
| GAF |
|
|
| −0.120 | 0.971 | 0.575 |
| CPZ dose equivalence | −0.349 | 0.128 | 0.0943 | 0.127 | 0.971 | 0.555 |
P_corr, FDR corrected P; P_uncor, uncorrected P. Bold characters indicate p values < 0.05.
PANSS, Positive and Negative Syndrome Scale; T, total score; P, positive; N, negative; G, general; GAF, Global Assessment of Functioning Scale; CPZ, chlorpromazine; T1w, T1‐weighted; T2w, T2‐weighted.
Figure 4Gray matter (GM) regions in the schizophrenia (SZ) brain where the T1w/T2w ratio image signal intensity values were significantly different from those in healthy control (HC) subjects. The right ventral putamen (including the nucleus accumbens) was identified using a voxel‐wise two‐sample t‐test (P family‐wise error [family‐wise error, FWE] < 0.01). See Table 4 for the Montreal Neurological Institute (MNI) coordinates of the region. Scale: t score.
GM regions where significant differences were found in the T1w/T2w ratio image between HC and SZ subjects
| Identified Regions | MNI (mm) | Peak FWE | Cluster FWE |
|
| Cluster size | ||
|---|---|---|---|---|---|---|---|---|
|
|
|
| Corrected | Corrected | ||||
| Right ventral putamen | 20 | 10 | −8 | 0.024 | 0.014 | 5.55 | 4.92 | 4 |
GM, gray matter; SZ, schizophrenia; HC, healthy control; MNI, Montreal Neurological Institute; FWE, family‐wise error.
Figure 5Distribution of the regions with relatively high signal intensity difference in T1w/T2w image between healthy control (HC) and schizophrenia (SZ). Regions with significantly different signal intensity (uncorrected P < 0.001 and cluster size threshold = 0) between HC and SZ are shown for Gray matter (GM) (left) and white matter (WM) (right). Age, gender, handedness, WM volume, and cerebrospinal fluid (CSF) volume were included as nuisance covariates. As seen, in both GM and WM, the regions were distributed widely in the brain but rather accumulated in the ventral frontal lobes and the temporal lobes.
Brain volume differences between HC and SZ subjects
| SZ | HC | Group difference | |
|---|---|---|---|
| Total gray matter volume (mm3) | 693.39 ± 84.43 | 712.68 ± 60.93 | 0.302 ( |
| Total white matter volume (mm3) | 516.86 ± 65.03 | 538.90 ± 49.47 | 0.136 ( |
| Cerebrospinal fluid (mm3) | 359.34 ± 41.50 | 344.44 ± 47.70 | 0.198 ( |
| Intracranial volume (mm3) | 1569.60 ± 180.16 | 1596.00 ± 149.12 | 0.632 ( |
SZ, schizophrenia; HC, healthy control.